LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. Stream NBC 5 for free, 24/7 ...

Sarin added that the company isn't done yet, with more data due in the next 18 months. In the past six months, the company's stock has surged nearly 20%, trading at $79 per share Thursday.

Aradhana Sarin: Sure. So we do expect an increase in CapEx and we won’t give specific CapEx guidance, obviously but I can give you some color on where that increase is coming from. So firstly ...

AstraZeneca named a new CFO, and its current CFO will become its chief strategy officer and the CEO of Alexion, the drugmaker announced June 4. In December 2020, AstraZeneca said it was acquiring ...

This week, I take a closer look at companies’ climate initiatives in light of COP29 and Trump’s return and talk to AstraZeneca CFO Aradhana Sarin. But first, ...

Aradhana Sarin told CNBC the company was in a “very unique space” regarding impact from rising geopolitical tensions between China and the west. Skip to content. Main Navigation.

Operator: Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe and good evening to those listening in Asia. - Part 17 ...